期刊文献+

食管鳞癌患者血清组织蛋白酶X水平检测及其临床意义

Clinical significance of serum Cathepsin X levels in patients with esophageal squamous cell carcinoma
原文传递
导出
摘要 目的研究血清组织蛋白酶X(Cathepsin X,Cat X)在食管鳞癌中的临床意义。方法应用酶联免疫吸附技术(enzyme linked immunosorbent assay,ELISA)检测65例食管鳞癌患者、35例健康体检者中血清Cat X的含量,分析血清Cat X的表达水平与食管鳞癌患者临床病理特征之间的关系。结果食管鳞癌患者血清Cathepsin X水平明显高于健康体检者(P<0.01),食管鳞癌患者血清Cathepsin X水平的高低与食管鳞癌的分期、淋巴结转移情况显著相关(P<0.05)。结论血清Cat X可能成为一种新的肿瘤标志物,有助于食管鳞癌的早期诊断、预后预测,以及侵袭转移情况的判断。 Objective To investigate the clinical significance of serum Cathepsin X in esophageal squamous cell carcinoma. Methods Levels of serum Cat X in 65 cases of esophageal squamous cell carcinoma patients and 35 cases of healthy persons was determined by ELISA, and to analyze the relationship between the expression level of serumCatX and the clinicopathologicalfeatures of esophageal squamons cell carcinoma patients. Results The level of serum Cathepsin X in patients with esophageal squamous cell carcinoma was significantly higher than that in healthy subjects (P 〈 0. 01 ), and the level of serum Cathepsin X in patients with esophageal squamous cell carcinoma was significantly correlated with the stage of esophageal squamous cell carcinoma and lymph node metastasis( P 〈0. 05 ). Conclusion Serum Cat X might serve as a new tumor marker, which is helpful for the early diagnosis, prognosis prediction, and the judgment of the invasion and metastasis of esophageal squamous cell carcinoma.
出处 《医药论坛杂志》 2016年第6期17-19,共3页 Journal of Medical Forum
关键词 CathepsinX 食管鳞癌 血清 ELISA CathepsinX Esophageal squamous cell carcinoma Serum ELISA
  • 相关文献

参考文献14

  • 1Mandard AM, Hainaut P, Hollstein M. Genetic steps in the de-velopment of squamous cell carcinoma of the esophagus[J]. Mu-tat Res,2000,462(2-3) : 335-342.
  • 2Kos J, Jevnikar Z, Obermajer N. The role of cathepsin X in cell8ignaling[J]. Cell AdhMigr, 2009, 3(2) : 164-166.
  • 3Obermajer N, Jevnikar Z,Doljak B, et al. CathepsinX - media-ted 卩2 - integrin activation results in nanotube outgrowth [J].Cell Mol Life Sci, 2009,66(6) : 1126-1134.
  • 4Nascimento FD, Rizzi CC, Nantes IL, et al. Cathepsin X bindsto cell surface heparan sulfate proteoglycans[J]. Arch Biochem-Biophys, 2005, 436(2) : 323-332.
  • 5Krueger S, Kalinski T, Hundertmark T,et al. Up - regulationof cathepsin X in Helicobacter pylori gastritis and gastric cancer[J]. J Pathol, 2005 , 207(1): 3242.
  • 6Nagler DK, Kruger S, Kellner A, et al. Upregulation of Cathep-sin X in prostate cancer and prostatic intraepithelial neoplasia[J]. Prostate, 2004, 60(2) : 109-119.
  • 7Rumpler G, Becker B, Hafner C, et al. Identification of differ-entially expressed genes in models of melanoma profession bycDNA array analysis : SPARC,MIF and a novel cathepsin prote-ase characterize aggressive phenotypes[J]. ExpDermatol, 2003,12(6) : 761-771.
  • 8Hidaka S,Yasutake T, Takeshita H, et al. Differences in20ql3.2 copy number between colorectal cancers with and with-out liver metastasis[J]. Clin Cancer Res, 2000, 6(7) : 2712-2717.
  • 9Bar - Shira A, Pinthus HJ, Rozovsky U, et al. Multiple genesin human 20ql3 chromosomal region are involved in an advancedprostate cancer xenograft. Cancer Res, 2002, 62 ( 23 ) : 6803-6807.
  • 10Cao XF, He XT, Ji L, et al. Effects of neoadjuvant radiochemo-therapy on pathological staging and prognosis for locally advancedesophageal squamous cell carcinoma [ J ]. Dis Esophagus,2009,22(6) : 477481.

二级参考文献23

  • 1Choi HJ, Gyun MS, Jun GJ, et al. Tumor angiogenesis as a prog- nostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence [ J ]. Oncology, 2008,55 ( 5 ) : 575-581.
  • 2Salvesen HB, Iversen OE, Akslen LA. Independent prognostic im- portance of microvessel density in endometrial carcinoma[J]. Br J Cancer, 2008,77 ( 12 ) : 1140-1144.
  • 3Kumar S, Ghellal A, Li C, et al. Breast carcinoma : Vascular den- sity determined using CDl05 an-tibody correlates with tumor progno- sis[J]. Cancer Res, 2009,59(2) :856-861.
  • 4Lu C, Tanigawa N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma [ J ]. Cancer Res, 2007,57(10) :221-224.
  • 5Sugamura K, Makino M, Kaibara. Apoptosis as a prognostic factor in colorectal carcinoma[ J ]. Surg Today, 1998,28 ( 7 ) : 145-150.
  • 6Ikeguchi M, Cai J, Yamane N,et al. Clinical significance of spon- taneous apoptosis in advanced gastric adenocareinoma [ J ]. Canc- er, 2009,85 ( 11 ) :2329-2335.
  • 7Furukawa T, Yoshimura A, Sumizawa T, et al. Angiogenic factor [ J]. Nature, 2002,356(42) :668-670.
  • 8Ishikawa F, Miyazono K, Hellman U, et al. Identification of an- giogenic activity and the cloning and expres-sion of platelet-derived endothelial-cell growth factor [ J ]. Nature, 2009, 338 ( 15 ) : 557-562.
  • 9Fox SB, Westwood M, Moghaddam A, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phospho- rylase is up-regulated in breast cancer epithelium and endothelium [J]. Br J Cancer, 2006,73(19) :275-280.
  • 10Takebayashi Y, Kamada K, Miyadera K, et al. The activity and expression of thymidine phos-phorylase in human solid tumors[ J]. Eur J Cancer, 2006,32A(3 ) : 1227-1232.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部